Novanta Inc

Novanta Inc. tops Q1 2026 earnings expectations with 10% revenue rise and 21% EPS jump, driving strong growth in precision photonics and motion‑control markets.

Novanta’s $550 million tangible‑equity unit sale fuels precision photonics growth—boosting product development, manufacturing and future revenue toward a $400 million target by 2030.

Novanta’s precision photonics and motion control tech powers medical & industrial innovation, driving high valuation and growth potential for investors.

Novanta, Inc. is a US-based company that specializes in precision photonics and motion control components, serving the medical equipment and advanced industrial technology markets with a strong financial foundation and commitment to innovation.